Allergic Rhinitis
479
24
35
329
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
69 trials with published results (14%)
Research Maturity
329 completed trials (69% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.9%
14 terminated out of 479 trials
95.9%
+9.4% vs benchmark
29%
139 trials in Phase 3/4
21%
69 of 329 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 329 completed trials
Clinical Trials (479)
Observational Study of RHINOSEDAL in Acute Nasal Obstruction
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa
Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis
Facilitating Surgical Choice in Patient With Chronic Hypertrophic Rhinitis Using a Patient Decision Aid
EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
Effect of the Probiotic ES1 and Its Inactivated Form (HT-ES1) Over Symptomatology Asociated With Allergic Rhinitis
Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis
The Effect of Oral Probiotics on Allergic Rhinitis Symptoms and the Quality of Life
Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters
Effects of Adenoidectomy on Symptoms and IgE Levels in Children With AR
Dietary Intervention on Atopy
Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project
Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies
Acupuncture for Nasal Congestion in Allergic Rhinitis
Free Diving Breathing Training in Allergic Rhinitis
Safety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With Asthma
INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION